Skip to content

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Steven H. Swerdlow, Elías Campo, Stefano Aldo Pileri, Nancy L. Harris, Harald Stein, Reiner Siebert, Ranjana H. Advani, Michele E. G. Ghielmini, Gilles Andre Salles, Andrew David Zelenetz, Elaine S. Jaffe

Blood · 2016 · 8,061 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R. H., Ghielmini, M. E. G., Salles, G. A., Zelenetz, A. D., & Jaffe, E. S. (2016). The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood, 127(20), 2375–2390. https://doi.org/10.1182/blood-2016-01-643569

In text: (Swerdlow et al., 2016)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

A revision of the nearly 8-year-old World Health Organization classification of the lymphoid neoplasms and the accompanying monograph is being published. It reflects a consensus among hematopathologists, geneticists, and clinicians regarding both updates to current entities as well as the addition of a limited number of new provisional entities. The revision clarifies the diagnosis and management of lesions at the very early stages of lymphomagenesis, refines the diagnostic criteria for some entities, details the expanding genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates, and refers to investigations leading to more targeted therapeutic strategies. The major changes are reviewed with an emphasis on the most important advances in our understanding that impact our diagnostic approach, clinical expectations, and therapeutic strategies for the lymphoid neoplasms.

  1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma2017
  2. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification2014
  3. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma2002
  4. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia2002
  5. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma1993

Metadata from OpenAlex (CC0). Citations are generated from the published record.